Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Vaccine

• Publication date

  2009-05-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2009.03.023PMID 19428922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses.

  2008cited by this paper
• Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and Mice

  2008cited by this paper
• Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens

  2008cited by this paper
• Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules.

  2008cited by this paper
• Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

  2007cited by this paper
• Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

  2007cited by this paper
• H5N1 Viruses and Vaccines

  2007cited by this paper
• Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.

  2007cited by this paper
• Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice.

  2007cited by this paper
• Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

  2006cited by this paper
• Strategies for developing vaccines against H5N1 influenza A viruses.

  2006cited by this paper
• Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

  2006cited by this paper
• Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.

  2006cited by this paper
• Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control.

  2006cited by this paper
• Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.

  2006cited by this paper
• Making Better Influenza Virus Vaccines?

  2006cited by this paper
• Predicting the global spread of H5N1 avian influenza

  2006cited by this paper
• From Plasmids to Protection: A Review of DNA Vaccines Against Infectious Diseases

  2006cited by this paper
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

  2005cited by this paper
• Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus

  2005cited by this paper
• Characterization of the 1918 influenza virus polymerase genes

  2005cited by this paper
• Codon Optimization of the Tat Antigen of Human Immunodeficiency Virus Type 1 Generates Strong Immune Responses in Mice following Genetic Immunization

  2004cited by this paper
• Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

  2004cited by this paper
• DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

  2002cited by this paper
• Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic

  2002cited by this paper
• Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

  2000cited by this paper
• DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in Mice

  1999cited by this paper
• Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

  1999cited by this paper
• Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA

  1998cited by this paper
• Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

  1997cited by this paper
• Evolution and ecology of influenza A viruses

  1992cited by this paper
• Codon usage patterns in Escherichia coli, Bacillus subtilis, Saccharomyces cerevisiae, Schizosaccharomyces pombe, Drosophila melanogaster and Homo sapiens; a review of the considerable within-species diversity.

  1988cited by this paper

• Dual Gene Detection of H5N1 Avian Influenza Virus Based on Dual RT-RPA

  2024cites this paper
• Advances in Detection Techniques for the H5N1 Avian Influenza Virus

  2023cites this paper
• Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection

  2016cites this paper
• Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA).

  2016cites this paper
• Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines

  2016cites this paper
• Evaluation of Liposome, Heat-Killed Mycobacterium w, and Alum Adjuvants in the Protection Offered by Different Combinations of Recombinant HA, NP proteins, and M2e Against Homologous H5N1 Virus

  2016cites this paper
• Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice

  2015cites this paper
• Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.

  2015cites this paper
• Comparison of different ELISA protocols for the detection of IgA against influenza nucleoproteins in trachea of vaccinated chickens.

  2015cites this paper
• Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines

  2014cites this paper
• Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes.

  2014cites this paper
• CD40 Ligand Preferentially Modulates Immune Response and Enhances Protection against Influenza Virus

  2014cites this paper
• Novel Technologies for Vaccine Development

  2014cites this paper
• Vaccine technologies against avian influenza: current approaches and new directions.

  2014cites this paper
• A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses.

  2013cites this paper
• A Single Electroporation Delivery of a DNA Vaccine Containing the Hemagglutinin Gene of Asian H5N1 Avian Influenza Virus Generated a Protective Antibody Response in Chickens against a North American Virus Strain

  2013cites this paper
• A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection

  2013cites this paper
• Synthetic nanoparticle-based vaccines against respiratory pathogens

  2013cites this paper
• Targeting the Highly Conserved Sequences in Influenza A Virus

  2013cites this paper
• DNA vaccination in the skin using microneedles improves protection against influenza.

  2012cites this paper
• Pentamers Not Found in the Universal Proteome Can Enhance Antigen Specific Immune Responses and Adjuvant Vaccines

  2012cites this paper
• Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1

  2012cites this paper
• Prior infection of chickens with H1N1 avian influenza virus elicits heterologous protection against highly pathogenic H5N2.

  2012cites this paper
• Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge

  2012cites this paper
• Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets.

  2012cites this paper
• Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines

  2012cites this paper
• Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.

  2012cites this paper
• Evaluation of mismatched immunity against influenza viruses

  2012cites this paper
• DENDRITIC CELL-TARGETED NANOPARTICLES FOR THE DELIVERY OF DNA AND PROTEIN VACCINES

  2012cites this paper
• The impact of codon optimization in H5N1 vaccine

  2012cites this paper
• Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans

  2012cites this paper
• Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.

  2012cites this paper
• Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets.

  2011cites this paper
• Development and strategies of cell-culture technology for influenza vaccine

  2011cites this paper
• Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

  2011cites this paper
• Title A recombinant vaccine of H 5 N 1 HA 1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H 5 N 1 viruses

  2011cites this paper
• Identification of critical motifs within HIV-1 integrase required for importin α3 interaction and viral cDNA nuclear import.

  2011cites this paper
• Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin.

  2011cites this paper
• Universal protein vaccines against Neisseria meningitidis serogroup B, Streptococcus pneumoniae and influenza

  2011cites this paper
• A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses

  2011cites this paper
• Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine.

  2010cites this paper
• Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines

  2010cites this paper
• Development and evaluation of DNA vaccines in chickens against a wild bird H6N2 avian influenza virus from Western Australia

  2010influential citation
• Research and development of universal influenza vaccines.

  2010cites this paper
• Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutinin.

  2010cites this paper
• Influenza pathogenesis: lessons learned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza.

  2010cites this paper
• Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant.

  2010cites this paper
• Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret

  2010cites this paper
• Influenza pathogenesis : Lessons earned from animal studies with H 5 N 1 , H 1 N 1 Spanish , and pandemic H 1 N 1 2009 influenza

  2009cites this paper
• Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys

  2009cites this paper
• Against Influenza Virus Immune Response and Enhances Protection Cd40 Ligand Preferentially Modulates

  year unknowncites this paper
• Against Influenza Virus Immune Response and Enhances Protection Cd40 Ligand Preferentially Modulates

  year unknowncites this paper